AzTrials
AzTrials

ObesityWISE HealthNCT06284681

Weight Inclusive and Adaptive Strategies to Enhance Cardiometabolic Health in Black Adults

A study testing Weight-focused health coaching, Weight-neutral health coaching and Intensify lifestyle approach in people with Obesity and Prehypertension, run by University of Alabama at Birmingham at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The proposed 6-month pilot Sequential Multiple Assignment Randomize Trial (SMART) has two aims. The first and primary aim is to determine the feasibility of conducting a full-scale SMART to compare weight-focused (i.e., weight loss) and weight-neutral (i.e., weight loss is not an explicit goal) adaptive biobehavioral… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Obesity, Prehypertension, Hypertension
What is being tested?
Weight-focused health coaching, Weight-neutral health coaching and Intensify lifestyle approach
Could I receive a placebo?
No, everyone receives an active treatment
How many people
41 participants
Where
1 siteUnited States
Study dates
1 Oct 2024to 31 Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Black or African American Race
  • ≥18 years
  • BMI ≥27 kg/m2 plus a diagnostic history of 1 or more of the following:
  • Prehypertension or hypertension
  • Prediabetes or type 2 diabetes
  • Dyslipidemia
Show all 11Show fewer
  • Has a primary care provider who is willing to participate in enhanced medical management condition as needed
  • Access and ability to use a device with reliable internet connectivity
  • Able to converse and read English
  • Willingness to enroll in any possible intervention conditions
  • Willingness to engage in post-intervention focus group

Who cannot join

  • Presence of any condition precluding engagement in the prescribed diet or exercise interventions
  • Currently engaged in a structured lifestyle-based or weight loss intervention

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Alabama at Birmingham

    Birmingham, Alabama, 35294

Other trials in United States

About this study

Official title: Weight-focused vs. Weight-neutral Adaptive Biobehavioral Strategies for Improving Metabolic Health in Black Adults With Stage 1 Obesity: A Pilot Sequential Multiple Assignment Randomized Trial

The proposed 6-month pilot Sequential Multiple Assignment Randomize Trial (SMART) has two aims. The first and primary aim is to determine the feasibility of conducting a full-scale SMART to compare weight-focused (i.e., weight loss) and weight-neutral (i.e., weight loss is not an explicit goal) adaptive biobehavioral interventions for improving cardiometabolic health in Black adults with overweight or obesity (BMI ≥27 kg/m2) plus at least one weight-related cardiometabolic condition (high blood pressure, prediabetes or diabetes, and/or high cholesterol). Biobehavioral interventions are treatment strategies that combine lifestyle-based behavioral interventions such as eating a healthy diet and exercise with medications. In this study, participants will be randomly assigned to receive either weight-focused or weight-neutral health coaching for 7 weeks. At week 8, participants will be identified as either "responders" or "nonresponders" to the initial interventions. The threshold for response in the weight-focused condition is greater than or equal to 3% weight loss. The threshold for response in the weight-neutral condition is engaging in greater than or equal to 150 minutes of moderate physical activity for the 7 days prior to the week 8 study visit. Responders to the initial interventions will continue with health coaching on a biweekly basis for weeks 9-26 of the intervention. Nonresponders will be re-randomized to either intensify the lifestyle-based intervention by receiving a membership to the YMCA and enrolling in group fitness classes or augmenting the health coaching with enhanced medical management in partnership with their established primary care provider. The second aim is to use clinical data from the pilot SMART to estimate treatment effects and the between-person variability in these effects. Because this is a pilot study, these estimates will not be used to make comparisons or draw conclusions on the comparative effectiveness of intervention conditions. Rather, these data will be used to generate preliminary effect sizes that can be used to estimate the sample size required for a full-scale trial. Clinical trial feasibility data will be collected on an ongoing basis throughout the study and clinical data will be collected prior to initiating the intervention (baseline) and at week 8 (response visit) and week 26 (post-intervention visit).

Being tested
Weight-focused health coaching, Weight-neutral health coaching, Intensify lifestyle approach, Augment with enhanced medical management
Medical subject headings
Obesity, Prehypertension, Hypertension, Prediabetic State, Diabetes Mellitus, Type 2, Dyslipidemias

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Weight-focused health coachingBehavioural

    Following the definition of structured lifestyle interventions within the current obesity clinical practice guidelines, the weight-focused health coaching intervention will be delivered as a multi-component behavior change intervention intended to produce clinically-important weight loss through consuming a healthy, energy-restricted diet and increasing physical activity.

  • Weight-neutral health coachingBehavioural

    Dietary and physical activity prescriptions for the weight-neutral health coaching intervention will be similar to the weight-focused intervention except the diet prescription will be designed to fully meet daily estimated energy requirements rather than creating a negative energy balance and producing weight loss. Health coaches will not emphasize changes in body weight as an explicit goal or as a mediator of improved cardiometabolic health. Rather, health coaches will emphasize achieving diet and exercise behavioral goals as a direct means to improving cardiometabolic health independently of changes in body weight.

  • Intensify lifestyle approachBehavioural

    Participants identified as non-responders to initial health coaching interventions may be re-randomized to receive a 4-month membership to the local YMCA and health coaches will assist participants in identifying and enrolling in at least 2 weekly group fitness classes at the YMCA.

  • Augment with enhanced medical managementOther

    Participants identified as non-responders to initial health coaching interventions may be re-randomized to meet with the primary care provider and health coach to consider additional or revised medication plans to address their weight and weight-related chronic conditions.

Study groups in NCT06284681
Study groupRoleWhat they receive
Weight-Focused Health Coaching with Intensified Lifestyle Approach for NonrespondersActive comparatorParticipants will start with weight-focused health coaching for 7 weeks and individuals achieving <3% weight loss will be given a 4-month membership to the YMCA and enrolled in group fitness classes.
Receives: Behavioral: Weight-focused health coaching; Behavioral: Intensify lifestyle approach
Weight-Neutral Health Coaching with Intensified Lifestyle Approach for NonrespondersActive comparatorParticipants will start with weight-neutral health coaching for 7 weeks and individuals achieving <150 minutes of moderate physical activity will be given a 4-month membership to the YMCA and enrolled in group fitness classes.
Receives: Behavioral: Weight-neutral health coaching; Behavioral: Intensify lifestyle approach
Weight-Focused Health Coaching with Enhanced Medical ManagementActive comparatorParticipants will start with weight-focused health coaching for 7 weeks and individuals achieving <3% weight loss will meet with their primary care provider and health coach to consider additional or revised medication plans to address their weight and weight-related chronic conditions.
Receives: Behavioral: Weight-focused health coaching; Other: Augment with enhanced medical management
Weight-Neutral Health Coaching with Enhanced Medical ManagementActive comparatorParticipants will start with weight-neutral health coaching for 7 weeks and individuals achieving <150 minutes of moderate physical activity will meet with their primary care provider and health coach to consider additional or revised medication plans to address their weight and weight-related chronic conditions.
Receives: Behavioral: Weight-neutral health coaching; Other: Augment with enhanced medical management
Weight-Focused Health Coaching OnlyActive comparatorThis arm includes participants who responded to Weight-Focused Health Coaching in stage 1.
Receives: Behavioral: Weight-focused health coaching
Weight-Neutral Health Coaching OnlyActive comparatorThis arm includes participants who responded to Weight-Neutral Health Coaching in stage 1.
Receives: Behavioral: Weight-neutral health coaching

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Recruitment rate

    Time required to meet recruitment goal

    Measured: baseline

  2. Retention rate

    Number and proportion of participants completing the study

    Measured: week 26

  3. Response/Non-response rate to initial interventions

    The proportion of participants meeting pre-specified response criteria initial interventions

    Measured: week 8

  4. Attendance to health coaching sessions

    Number and proportion of health coaching sessions attended attendance

    Measured: week 26

  5. Treatment Credibility and Expectancy Questionnaire (CEQ)

    The CEQ measures how much the participant believes in the rationale for the study treatments and how much they expect the treatments to improve their health.

    Measured: baseline

  6. Treatment Credibility and Expectancy Questionnaire (CEQ)

    The CEQ measures how much the participant believes in the rationale for the study treatments and how much they expect the treatments to improve their health.

    Measured: week 8

  7. Treatment Preference

    Measures the participant's preference for different treatments used in the study.

    Measured: baseline

  8. Treatment Preference

    Measures the participant's preference for different treatments used in the study.

    Measured: week 8

  9. Family medicine clinic capacity for research

    Measurement of family medicine clinic capacity for research

    Measured: week 26

  10. Study visit duration

    Measurement of study visit duration

    Measured: week 26

  11. Time required for surveys completion

    Measurement of time required for participants to complete the survey packet completion

    Measured: week 26

  12. Response to weight-focused health coaching

    Weight loss measured using family medicine clinic. scale. Greater than or equal to 3 percent weight loss is the threshold for "response" for the weight focused condition.

    Measured: Week 8

  13. Response to weight-neutral health coaching measurement

    Physical activity measured accelerometry (activPAL4). Greater than or equal to 150 weekly minutes of physical activity is the threshold for response for the weight-neutral condition.

    Measured: Week 8

Secondary outcomes (10)
  1. Change in blood pressure

    Measured by mercury sphygmomanometer

    Measured: Week 26

  2. Change in glucose

    Fasting blood draw

    Measured: Week 26

  3. Change in insulin

    Fasting blood draw

    Measured: Week 26

  4. Change in insulin sensitivity

    Measured by the quantitative insulin sensitivity check index (QUICKI). QUICKI is derived from measures of fasting insulin and fasting glucose, and a QUICKI score below 0.357 indicates low insulin sensitivity.

    Measured: Week 26

  5. Change in HbA1c

    Fasting blood draw

    Measured: Week 26

  6. Change in total cholesterol

    Fasting blood draw

    Measured: Week 26

  7. Change in LDL-cholesterol

    Fasting blood draw

    Measured: Week 26

  8. Change in HDL-cholesterol

    Fasting blood draw

    Measured: Week 26

  9. Change in triglycerides

    Fasting blood draw

    Measured: Week 26

  10. Change in Metabolic Syndrome Severity Score

    Metabolic Syndrome Severity Scores below zero indicate a lower degree of metabolic syndrome compared to the average adult, scores near zero indicate an average degree of metabolic syndrome, and scores above zero indicate an above average degree of metabolic syndrome and future disease risk.

    Measured: Week 26

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Feb 2024
  2. Study start1 Oct 2024
  3. Primary completion31 Jan 2026
  4. Study completion31 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Sequential
Masking
Single blind
Who is masked
Investigator
Enrolment
41 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06284681
Sponsor's protocol ID
IRB-300012557
Other IDs
3P50MD017338-03S1
Acronym
WISE Health
Status last verified
Feb 2026
First submitted
6 Feb 2024
Last updated
27 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Coded and cleaned scientific data - with all participant identifiers removed - from all time points and supporting information will be preserved and shared from resulting publication(s) to allow for validation and replication of the study. All participant identifying information (e.g., names, addresses, contact information) will be saved in a separate and secure file for future contact purposes via IRB-approved study personnel and protocols only. Study-related data will be available via PubMed Central following publication.

Questions about this trial

What is this clinical trial studying?

A study testing Weight-focused health coaching, Weight-neutral health coaching and Intensify lifestyle approach in people with Obesity and Prehypertension, run by University of Alabama at Birmingham at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Recruitment rate (time frame: baseline). The study lists 13 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in